Clinical Trial Update: Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease [Phase 1, Phase 2]

View source ↗

Summary

This is an early-phase trial evaluating radiation therapy followed by intrathecal trastuzumab and pertuzumab for HER2-positive breast cancer with leptomeningeal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Leptomeningeal Disease
• Leptomeningeal Metastasis

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Perjeta (pertuzumab)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: HER2-positive Breast Cancer, Leptomeningeal Metastasis | Phase 1, Phase 2 | Status: RECRUITING